Latest News in the pharma Industry

Research & Development

FDA Grants Genentech's Cobimetinib Priority Review for Use in Combination with Zelboraf in Advanced Melanoma

FDA Grants Genentech's Cobimetinib Priority Review for Use in Combination with Zelboraf in Advanced Melanoma

19 Feb 2015

Read more 
Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases

Sanofi and Lead Pharma to Develop Treatments for Autoimmune Diseases

19 Feb 2015

Read more 
Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

18 Feb 2015

Read more 
NIH Researchers Reveal Link Between Powerful Gene Regulatory Elements and Autoimmune Diseases

NIH Researchers Reveal Link Between Powerful Gene Regulatory Elements and Autoimmune Diseases

17 Feb 2015

Read more 
Novartis' Heart Failure Medicine LCZ696 Granted FDA Priority Review

Novartis' Heart Failure Medicine LCZ696 Granted FDA Priority Review

16 Feb 2015

Read more 
AbbVie Submits NDA in Japan for its Investigational, All-Oral, Treatment for Chronic Hepatitis C

AbbVie Submits NDA in Japan for its Investigational, All-Oral, Treatment for Chronic Hepatitis C

13 Feb 2015

Read more 
New Source of Cells for Modeling Malaria

New Source of Cells for Modeling Malaria

6 Feb 2015

Read more 
Genentech’s Phase III Study of Gazyva Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma

Genentech’s Phase III Study of Gazyva Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma

4 Feb 2015

Read more 
Pierre Fabre Pharmaceuticals Initiates Phase IIa Clinical Trial Programme for F17464 in Schizophrenia

Pierre Fabre Pharmaceuticals Initiates Phase IIa Clinical Trial Programme for F17464 in Schizophrenia

3 Feb 2015

Read more 
Novel Organoid Matrix Enables Long-Term Culture of Human Hepatocytes

Novel Organoid Matrix Enables Long-Term Culture of Human Hepatocytes

30 Jan 2015

Read more 
Regeneron and Sanofi Announce Praluent BLA has Been Accepted for Priority Review by FDA

Regeneron and Sanofi Announce Praluent BLA has Been Accepted for Priority Review by FDA

26 Jan 2015

Read more 
Clinical Studies Gain Pace as Pharmaceutical Industry Helps to Wage War on Diabetes Pandemic

Clinical Studies Gain Pace as Pharmaceutical Industry Helps to Wage War on Diabetes Pandemic

23 Jan 2015

Read more